Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |